Nuvectis PharmaNVCT
13F holders, Q1 2024 (March 31)40holders
2famous investors
$8.20avg. 13F price*
At the end of Q1 2024, 40 institutions reported holding Nuvectis Pharma Inc. (NVCT) in their 13F filings. The largest holders were BlackRock Inc. ($3.1M), Vanguard Group Inc. ($2.5M) and Baldwin Wealth Partners LLC ($1.3M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Nuvectis Pharma Inc.
- CUSIP
- 67080T108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 6 | $152K |
| Exits | 2 | $404K |
Ownership 40 holders
| BlackRock Inc. | 0.00% | Reduce -3.9% | 372,721 | $3.1M |
| Vanguard Group Inc. | 0.00% | Add +1.5% | 298,800 | $2.5M |
| Baldwin Wealth Partners LLC | 0.10% | Add +8.5% | 154,130 | $1.3M |
| Geode Capital Management, LLC | 0.00% | Add +2.2% | 134,528 | $1.1M |
| State Street Corp. | 0.00% | Add +9.4% | 129,379 | $1.1M |
| Northern Trust Corp. | 0.00% | Add +0.8% | 62,097 | $509K |
| Renaissance Technologies | 0.00% | Add +19.1% | 61,700 | $506K |
| Marshall Wace, LLP | 0.00% | Add +101.8% | 50,068 | $411K |
| Morgan Stanley | 0.00% | Add +79.8% | 41,191 | $338K |
| Millennium Management | 0.00% | Add +16.1% | 39,501 | $324K |
| Gsa Capital Partners LLP | 0.03% | Add +43.8% | 39,282 | $322K |
| Forbes J M & Co. LLP | 0.03% | No change | 34,000 | $279K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 19,920 | $163K |
| Edmond DE Rothschild Holding S.A. | 0.00% | No change | 19,170 | $157K |
| Bank of New York Mellon Corp | 0.00% | Reduce -7.3% | 17,755 | $146K |
| Blue Zone Wealth Advisors, LLC | 0.04% | New | 14,350 | $118K |
| Nuveen Asset Management, LLC | 0.00% | No change | 11,883 | $97K |
| Barclays PLC | 0.00% | Add +0.4% | 10,293 | $84K |
| UBS Group AG | 0.00% | Reduce -5.5% | 7,620 | $62K |
| Rhumbline Advisers | 0.00% | Add +3.1% | 7,502 | $62K |
| New York State Common Retirement Fund | 0.00% | Reduce -0.4% | 5,749 | $47K |
| STRS Ohio | 0.00% | Reduce -6.5% | 5,800 | $47K |
| JPMorgan Chase & Co. | 0.00% | Add +5.4% | 5,165 | $42K |
| Bank of America Corp. | 0.00% | Reduce -49.7% | 3,775 | $31K |
| American International Group, Inc. | 0.00% | Reduce -0.8% | 3,664 | $30K |
| Deutsche Bank AG | 0.00% | New | 3,509 | $29K |
| Wells Fargo & Company | 0.00% | Add +15.7% | 2,200 | $18K |
| Citigroup Inc. | 0.00% | Add +24.7% | 1,382 | $11K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -33.4% | 851 | $7K |
| Legal & General Group Plc | 0.00% | No change | 841 | $7K |
| California State Teachers Retirement System | 0.00% | Reduce -39.0% | 747 | $6K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 566 | $5K |
| Trust Co. of Vermont | 0.00% | New | 500 | $4K |
| FMR LLC | 0.00% | Add +21650.0% | 435 | $4K |
| Hollencrest Capital Management | 0.00% | No change | 280 | $2K |
| Amalgamated Bank | 0.00% | Reduce -76.2% | 231 | $2K |
| Royal Bank of Canada | 0.00% | Reduce -88.5% | 270 | $2K |
| Lanark Financial, Inc. | 0.00% | New | 100 | $1K |
| GAMMA Investing LLC | 0.00% | New | 25 | $205 |
| Avior Wealth Management, LLC | 0.00% | New | 1 | $8 |
"% of holder's portfolio" is NVCT's weight in each manager's 13F, not the share of Nuvectis Pharma Inc. the manager owns.